12 Posts
1 Comments

Paul Naphtali

Paul Naphtali is a PhD candidate at McMaster University and studies cystic fibrosis respiratory disease driven by bacterial infections. He specializes in the study of Pseudomonas-driven infections with genomics and transcriptomics.

A picture of Omicron spread in South Africa

The researchers who first reported the Omicron variant have published their findings about the discovery of Omicron a few days ago. I will explain how they discovered Omicron by summarizing some of the findings...

Free-range SARS-Cov-2 infections in free-ranging white-tailed deer

Merry Christmas and a Happy New Year to you all! I hope that you are all managing well with the Omicron variant and that you still have been able to spend time with your...

Staying ahead in the fight against antibiotic resistance: Developing a new class of antibiotics

While the article featured today is behind a paywall, here is the link to the paper anyway. During my PhD, our department holds weekly seminars for graduate students to share their work with their...

The new B.1.1.529 variant and Canada: a COVID-19 development to monitor

In Canada, we have been very fortunate to see a high vaccination rate and a relatively slow increase in SARS-Cov-2 cases compared with other countries. As a case in point, Ontario is seeing 927...

Neutrophil neutralized: A way for pathogens to drive cystic fibrosis airway disease

The link to the paper I'm writing about for my first Cystic Fibrosis (CF) Canada blog post can be found here1. As I mentioned in my blog update, I'm now a blogger for CF Canada....

Blog update!

It's been a quite a while since I made a blog post for Microbe Musings. Almost two months in fact. A lot has happened since my last blog post, all of which I'll get...

Latest articles

Sign up to receive news and updates

To be updated with all the latest news, offers and special announcements.

By signing up you agree to receive email newsletters, notifications and alerts from Covid Dark PRO. You can unsubscribe at any time.